<html>
<head>PUBMED IDs for MAGEA2</head>
<body bgcolor='#C5F0F2'><h1>MAGEA2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16774536/'>Heterogeneous expression of melanoma antigen (hMAGE) mRNA in mesenchymal neoplasia.</a> June 16  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18237105/'>Prognostic impact of cancer/testis antigen expression in advanced stage multiple myeloma patients.</a> February 2  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/21422315/'>The role of MAGEA2 in head and neck cancer.</a> May 24  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21558405/'>BORIS binding to the promoters of cancer testis antigens, MAGEA2, MAGEA3, and MAGEA4, is associated with their transcriptional activation in lung cancer.</a> October 25  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23574628/'>Preferential expression of cancer/testis genes in cancer stem-like cells: proposal of a novel sub-category, cancer/testis/stem gene.</a> January 5  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23574622/'>Analysis of a gene co-expression network establishes robust association between Col5a2 and ischemic heart disease.</a> August 21  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24481586/'>The adherens junction-associated protein 1 is a negative transcriptional regulator of MAGEA2, which potentiates temozolomide-induced apoptosis in GBM.</a> December 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24662835/'>Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer.</a> November 11  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/28342986/'>Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes.</a> March 27  2017<br></body></html>
